This cohort study uses data from the Taiwan National Health Insurance database to assess the association between use of non–vitamin K oral anticoagulants with vs without concurrent medications and risk of major bleeding in patients with nonvalvular atrial fibrillation.
This Viewpoint discusses use of non–vitamin K oral anticoagulants in treating atrial fibrillation.
This cohort study uses data from an atrial fibrillation registry to describe the proportion of patients on warfarin who had stable INR values over an 18-month period.
This Medical Letter review summarizes the newly available oral anticoagulants and compares them with commonly prescribed warfarin.
This narrative review summarizes stroke risk prediction tools and strategies to prevent stroke in patients with atrial fibrillation.
This Viewpoint discusses optimal dosing recommendations for new anticoagulant agents.
This analysis of data from Danish administrative registries reports that among patients receiving antithrombotic therapy after myocardial infarction, use of nonsteroidal anti-inflammatory drugs was associated with increased risk of bleeding and thrombotic events.
This Viewpoint discusses potental hazards related to the concomitant use of nonsteroidal anti-inflammatory drugs and antithrombotic therapy after myocardial infarction.
You currently have no searches saved.